A classic example regarding the interruption of the IFN-γ signaling pathway is the loss-of-function mutation of the JAK1/2 in tumor cells, notably of JAK2, which was detected in recurrent patients with melanoma treated with anti-PD1/L1 [18]. This evidence concerns the gene IFNG and neoplasm.